Study Group: Enbrel Prescribers for RA (US)(?)
Council Members in this Study Group: 25
Request a survey with this Study Group
Leading Experts in this Study Group
Partner
San Diego Arthritis Medical Clinic
Ara Dikranian, MD, is a Rheumatologist at San Diego Arthritis Medical Clinic, a single-specialty private practice in San Diego, California. Dr. Dikranian is board certified in Internal Medicine and Rheumatology. He completed his rheumatology training at the University of California San Diego. He has...
Herbert Baraf, MD, FACP, FACRClinical Associate Professor of Medicine
UNIVERSITY OF MARYLAND
Herbert Baraf, MD, FACP, FACR, is the Managing Partner of Arthritis and Rheumatism Associates and the Medical Director of Center for Rheumatology and Bone Research in Maryland. He is also the Clinical Professor of Medicine at George Washington University Medical Center and Clinical Associate Professor...
Rheumatologist
HEALTHCARE PARTNERS MEDICAL GROUP
Dipti Doshi, MD, is a board certified Rheumatologist at Health Care Partners Medical group, California. Dr. Doshi is also board certified in Internal Medicine. Her special interests are in rheumatoid arthritis, lupus, pain-related to scleroderma, fibromyalgia, and osteoarthritis. Dr. Doshi is interested...
Rheumatologist
Arthritis and Osteoporosis Treatment Center
Kenneth Nies, MD, FACP, is a Clinical Professor of Medicine at the University of California Los Angeles and is also in private practice at the Arthritis and Osteoporosis Treatment Center in Torrance, California. In addition to his clinical work, his background includes 10 years of academic medicine...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Drug therapies for RA include (NSAIDS), DMARDS, and, most recently, biologics. Biologics currently on the market for RA target immune messengers called cytokines, which promote the damaging inflammatory process, and include anti-tumor necrosis factor (TNF) drugs – infliximab , etanercept,adalimumab,...
Pharmacokinetic studies of Adlea showed that when it is locally administered to the site of pain, there appears to be limited systemic exposure. Its short duration of systemic exposure (hours) relative to the long duration of analgesia (12 weeks) resulting from a single treatment course of Adlea is...
Very important new treatment emerging in field of rheumatoid arthritis along with other drugs in pipeline. IL-6 receptor blocker. New Mechanism of action. Has positive priliminary endpoint results at 24 week study for RA compared to DMARD therapy alone.
New Actonel dosing and implication for market changes
Excellent study results. However, Osteonecrosis of the Jaw (ONJ) as reimbursement will effect this drugs usage.
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Academic Clinical Trial Center
- Academic Institution*
- Free-standing Surgery Center
- Private/For-Profit Healthcare Research Entity
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Partner
- Physician - Division Head
- Director
- Medical Director
- Physician - Fellow
- Chief Executive Officer
- Owner
- Physician - Chief Resident
- Professor
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms